6 April 2021
Oncimmune Holdings plc
("Oncimmune" or the "Company")
Block Listing Six Monthly Return
Oncimmune makes the following notification pursuant to Schedule Six of the AIM Rules for Companies regarding its existing block admission arrangements in respect of Oncimmune Holdings Plc 2016 Unapproved and EMI Share Option Plans (the "Share Option Plans").
| Name of applicant: | Oncimmune Holdings plc
|
| Name of scheme: | Oncimmune Holdings Plc 2016 Unapproved and EMI Share Option Plans
|
| Period of return: | 15 September 2020 to 15 March 2021
|
| Balance of unallotted securities under scheme(s) from previous return:
| 5,998,772 |
| Plus: The amount by which the block scheme(s) has been increased since the date of the last return (if any increase has been applied for):
| 0 |
| Less: Number of securities issued/allotted under scheme(s) during period:
| 168,618 |
| Equals: Balance under scheme(s) not yet issued/allotted at end of period:
| 5,830,154 |
For further information:
Oncimmune Holdings plc
Ron Kirschner, Company Secretary
Zeus Capital Limited (Nominated Adviser and Joint Broker)
Andrew Jones, Daniel Harris, Victoria Ayton
+44 (0)20 3829 5000
N+1 Singer (Joint Broker)
Aubrey Powell, Harry Gooden, Iqra Amin, James Fischer
+44 (0)20 7496 3000
WG Partners (Joint Broker)
David Wilson, Chris Lee
+44 (0)203 705 9321
Media enquiries:
FTI Consulting
Ben Atwell, Michael Trace, Alex Davis
+44 (0)20 3727 1000
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
